Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Simulations Plus Inc (SLP)

Simulations Plus Inc (SLP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 825,635
  • Shares Outstanding, K 19,967
  • Annual Sales, $ 59,580 K
  • Annual Income, $ 9,960 K
  • 60-Month Beta 0.73
  • Price/Sales 13.76
  • Price/Cash Flow 50.25
  • Price/Book 4.82
Trade SLP with:

Options Overview Details

View History
  • Implied Volatility 51.67% ( +3.06%)
  • Historical Volatility 32.70%
  • IV Percentile 88%
  • IV Rank 80.01%
  • IV High 63.83% on 02/14/24
  • IV Low 2.98% on 05/08/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 6
  • Volume Avg (30-Day) 15
  • Put/Call OI Ratio 1.44
  • Today's Open Interest 227
  • Open Int (30-Day) 325

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 02/29/24
See More
  • Average Estimate 0.18
  • Number of Estimates 1
  • High Estimate 0.18
  • Low Estimate 0.18
  • Prior Year 0.20
  • Growth Rate Est. (year over year) -10.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
40.45 +1.73%
on 03/01/24
44.95 -8.45%
on 03/21/24
-0.78 (-1.86%)
since 02/28/24
3-Month
35.98 +14.37%
on 02/05/24
45.66 -9.88%
on 12/29/23
-4.50 (-9.86%)
since 12/28/23
52-Week
32.69 +25.88%
on 10/27/23
52.69 -21.90%
on 08/08/23
-1.82 (-4.24%)
since 03/28/23

Most Recent Stories

More News
Simulations Plus: Fiscal Q1 Earnings Snapshot

Simulations Plus: Fiscal Q1 Earnings Snapshot

SLP : 41.15 (-0.48%)
Simulations Plus: Fiscal Q4 Earnings Snapshot

Simulations Plus: Fiscal Q4 Earnings Snapshot

SLP : 41.15 (-0.48%)
Simulations Plus: Fiscal Q3 Earnings Snapshot

Simulations Plus: Fiscal Q3 Earnings Snapshot

SLP : 41.15 (-0.48%)
Happy National Holidays

Monday U.S. Economic Lookahead ISM Manufacturing (June) Construction Spending ...

CULP : 4.80 (-0.62%)
SLP : 41.15 (-0.48%)
NUMI.TO : 0.1050 (+10.53%)
RCH.TO : 42.60 (-0.91%)
ATZ.TO : 37.40 (-0.51%)
The Zacks Analyst Blog Highlights Atlassian, Zscaler, Simulations Plus and Asure Software

Atlassian, Zscaler, Simulations Plus and Asure Software are part of the Zacks top Analyst Blog.

SLP : 41.15 (-0.48%)
ASUR : 7.78 (-1.52%)
TEAM : 195.11 (+1.02%)
ZS : 192.63 (-0.44%)
4 Low-Beta Tech Stocks to Hedge Against Market Uncertainty

Investors can consider adding four low-beta tech stocks like TEAM, ZS, SLP and ASUR in their portfolios to hedge against a highly-volatile market.

SLP : 41.15 (-0.48%)
ASUR : 7.78 (-1.52%)
TEAM : 195.11 (+1.02%)
ZS : 192.63 (-0.44%)
Simulations Plus Receives U.S. FDA Renewal for DILIsym Software Licenses

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that the U.S. FDA has renewed its licenses...

SLP : 41.15 (-0.48%)
Can Simulations Plus (SLP) Climb 53.66% to Reach the Level Wall Street Analysts Expect?

The mean of analysts' price targets for Simulations Plus (SLP) points to a 53.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts...

SLP : 41.15 (-0.48%)
Simulations Plus (SLP) Q2 Earnings Beat, Revenues Up Y/Y

Simulations Plus' (SLP) Q2 results are driven by higher revenues in Software and Services business segments.

SLP : 41.15 (-0.48%)
PERI : 22.48 (+0.54%)
PEGA : 64.64 (-0.71%)
ANET : 289.98 (+0.54%)
Simulations Plus (SLP) Surpasses Q2 Earnings Estimates

Simulations Plus (SLP) delivered earnings and revenue surprises of 11.11% and 2.54%, respectively, for the quarter ended February 2023. Do the numbers hold clues to what lies ahead for the stock?

SLP : 41.15 (-0.48%)
BLKB : 74.14 (+1.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab,...

See More

Key Turning Points

3rd Resistance Point 42.60
2nd Resistance Point 42.25
1st Resistance Point 41.70
Last Price 41.15
1st Support Level 40.81
2nd Support Level 40.46
3rd Support Level 39.91

See More

52-Week High 52.69
Fibonacci 61.8% 45.05
Fibonacci 50% 42.69
Last Price 41.15
Fibonacci 38.2% 40.33
52-Week Low 32.69

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar